- Home
- EDBL vs GOVX Comparison
EDBL vs GOVX Comparison
Compare EDBL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDBL
- GOVX
- Stock Information
- Founded
- EDBL 2020
- GOVX 2001
- Country
- EDBL United States
- GOVX United States
- Employees
- EDBL N/A
- GOVX N/A
- Industry
- EDBL Farming/Seeds/Milling
- GOVX Biotechnology: Pharmaceutical Preparations
- Sector
- EDBL Consumer Staples
- GOVX Health Care
- Exchange
- EDBL Nasdaq
- GOVX Nasdaq
- Market Cap
- EDBL 7.2M
- GOVX 7.6M
- IPO Year
- EDBL 2022
- GOVX N/A
- Fundamental
- Price
- EDBL $2.61
- GOVX $0.79
- Analyst Decision
- EDBL
- GOVX Strong Buy
- Analyst Count
- EDBL 0
- GOVX 4
- Target Price
- EDBL N/A
- GOVX $10.50
- AVG Volume (30 Days)
- EDBL 127.1K
- GOVX 2.8M
- Earning Date
- EDBL 08-13-2025
- GOVX 07-28-2025
- Dividend Yield
- EDBL N/A
- GOVX N/A
- EPS Growth
- EDBL N/A
- GOVX N/A
- EPS
- EDBL N/A
- GOVX N/A
- Revenue
- EDBL $13,443,000.00
- GOVX $5,591,576.00
- Revenue This Year
- EDBL $29.56
- GOVX N/A
- Revenue Next Year
- EDBL $20.00
- GOVX N/A
- P/E Ratio
- EDBL N/A
- GOVX N/A
- Revenue Growth
- EDBL N/A
- GOVX N/A
- 52 Week Low
- EDBL $1.80
- GOVX $0.43
- 52 Week High
- EDBL $39.50
- GOVX $11.18
- Technical
- Relative Strength Index (RSI)
- EDBL 45.87
- GOVX 49.37
- Support Level
- EDBL $2.54
- GOVX $0.60
- Resistance Level
- EDBL $2.76
- GOVX $0.88
- Average True Range (ATR)
- EDBL 0.13
- GOVX 0.08
- MACD
- EDBL 0.01
- GOVX 0.03
- Stochastic Oscillator
- EDBL 54.05
- GOVX 68.40
About EDBL Edible Garden AG Incorporated
Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.